FRIDAY, Jan. 27, 2023 — The U.S. Food and Drug Administration said Thursday it can't regulate CBD supplements because there isn't enough evidence on their safety. The agency also called on Congress to create new rules for what has become a…
You may also like
Trust in health care may significantly impact HPV...
CMS announces 2027 Medicare pay cut as ACR decries...
FDA widens Ryaltris approval, now for patients 6 years...
Tobramycin plus vancomycin may not reduce infection...
Cures Act complicates dissemination of cancer test...
Deadly NYC Legionnaires’ disease outbreak has a...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.